Efficacy of half-fluence photodynamic therapy depending on the degree of choroidal hyperpermeability in chronic central serous chorioretinopathy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology
Link
http://www.nature.com/articles/eye201313.pdf
Reference29 articles.
1. Piccolino FC, Borgia L, Zinicola E, Zingirian M . Indocyanine green angiographic findings in central serous chorioretinopathy. Eye 1995; 9: 324–332.
2. Spaide RF, Campeas L, Haas A, Yannuzzi LA, Fisher YL, Guyer DR et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology 1996; 103: 2070–2079 (discussion 2079–2080).
3. Gemenetzi M, De Salvo G, Lotery AJ . Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye 2010; 24: 1743–1756.
4. Spitznas M . Pathogenesis of central serous retinopathy: a new working hypothesis. Graefes Arch Clin Exp Ophthalmol 1986; 224: 321–324.
5. Spaide RF, Hall L, Haas A, Campeas L, Yannuzzi LA, Fisher YL et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 1996; 16: 203–213.
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Overlapping Spots of Photodynamic Therapy for Treatment of Choroidal Hemangioma in Sturge-Weber Syndrome: A Case Report;Case Reports in Ophthalmology;2024-04-30
2. Wait-and-see and other factors associated with recurrence risk in central serous chorioretinopathy patients: A systematic review and meta-analysis of cohort studies;F1000Research;2023-08-24
3. No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy;Ophthalmology and Therapy;2023-06-08
4. Half-Fluence, Half-Dose Photodynamic Therapy: Less Direct Damage but More Inflammation?;Pharmaceuticals;2023-03-27
5. No-Dose Photodynamic Therapy Against half-dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy;2022-10-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3